This study further confirmed that SBP modulates ECP activity through the PI3K/Akt/mTOR-signaling pathway, thereby suppressing the activation and degranulation of eosinophils and mitigating allergic rhinitis symptoms and related hyperimmune responses. This evidence concerns the gene AKT1 and allergic rhinitis.